½ÃÀ庸°í¼­
»óǰÄÚµå
1270484

¼¼°èÀÇ Ç÷´ç°è ½ÃÀå º¸°í¼­(2023³â)

Glucometer Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ç÷´ç°è ½ÃÀåÀº 2022³â 119¾ï 8,000¸¸ ´Þ·¯¿¡¼­ 2023³â¿¡´Â 131¾ï 2,000¸¸ ´Þ·¯·Î, CAGR 9.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î´Â COVID-19 ÆÒµ¥¹ÍÀ¸·ÎºÎÅÍÀÇ ¼¼°è °æÁ¦ ȸº¹ °¡´É¼ºÀ» È¥¶õ½ÃÄ×½À´Ï´Ù. ÀÌ ¾ç±¹ °£ÀÇ ÀüÀïÀº ´Ù¼öÀÇ ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°Ý ±Þµî, °ø±Þ¸Á È¥¶õÀ» ÃÊ·¡Çϰí, »óǰÀ̳ª ¼­ºñ½º Àüü¿¡ ÀÎÇ÷¹À̼ÇÀ» À¯¹ßÇÏ¿© ¼¼°èÀÇ ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Ç÷´ç°è ½ÃÀåÀº CAGR 9.2%·Î 2027³â¿¡´Â 186¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2022³â Ç÷´ç°è ½ÃÀå¿¡¼­´Â ºÏ¹Ì°¡ ÃÖ´ë Áö¿ªÀÌ µÇ¾ú½À´Ï´Ù. Ç÷´ç°è º¸°í¼­ ´ë»ó Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ¼­À¯·´, µ¿À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù.

´ç´¢º´ À¯º´·üÀÇ Áõ°¡´Â ÇâÈÄ Ç÷´ç°è ½ÃÀåÀÇ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´Àº Àå±âÀûÀÎ ´ë»ç ÁúȯÀÔ´Ï´Ù. Ç÷Áß Æ÷µµ´ç (Ç÷´çÀ̶ó°íµµ ÇÔ) ³óµµ°¡ ³ôÀº °ÍÀÌ Æ¯Â¡À̸ç Àå±âÀûÀ¸·Î ½ÉÀå, Ç÷°ü, ´«, ½ÅÀå ¹× ½Å°æ¿¡ Å« ÇØ¸¦ ³¢Ä¥ ¼ö ÀÖ½À´Ï´Ù. ´ç´¢º´ ȯÀÚ´Â Ç÷´ç°è¸¦ »ç¿ëÇÏ¿© Ç÷´ç ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇÕ´Ï´Ù. µû¶ó¼­ »ç¶÷µéÀÇ ´ç´¢º´ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ç÷´ç°è¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, º§±â¿¡¿¡ º»»ç¸¦ µÐ ºñ¿µ¸® ´ç´¢º´ ´ÜüÀÎ ±¹Á¦´ç´¢º´¿¬ÇÕ(International Diabetes Federation)ÀÌ ¹ßÇ¥ÇÑ Åë°è¿¡ µû¸£¸é 2021³â 12¿ù ±âÁØ 5¾ï 3700¸¸ ¸íÀÇ ¼ºÀÎ(20-79¼¼)ÀÌ ´ç´¢º´À» ¾Î°í ÀÖÀ¸¸ç, 670¸¸ ¸íÀÌ ´ç´¢º´À¸·Î »ç¸ÁÇÑ °ÍÀ¸·Î ±â·ÏµÆ½À´Ï´Ù. ±×·¯³ª 2030³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î 6¾ï 4,300¸¸ ¸íÀÌ ´ç´¢º´À» ¾Î°í ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µû¶ó¼­ ´ç´¢º´ À¯º´·üÀÇ Áõ°¡´Â Ç÷´ç°è ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Ç÷´ç°è ½ÃÀå Æ¯Â¡

Á¦3Àå Ç÷´ç°è ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå Ç÷´ç°è ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • COVID-19¿¡ ÀÇÇÑ Ç÷´ç°è ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¡¤·¯½Ã¾Æ ÀüÀïÀÌ Ç÷´ç°è ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • °íÀÎÇ÷¹À̼ÇÀÌ Ç÷´ç°è ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå Ç÷´ç°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ Ç÷´ç°è ½ÃÀå ½ÇÀû, 2017-2022³â
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ Ç÷´ç°è ½ÃÀå ¿¹Ãø, 2022-2027F, 2032F
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦6Àå Ç÷´ç°è ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ±â±â
  • Ç÷´çÀÚ°¡ÃøÁ¤ ½Ã½ºÅÛ
  • ¼¼°èÀÇ Ç÷´ç°è ½ÃÀå, ±â¼úº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ħ½ÀÀû
  • ºñħ½ÀÀû
  • ¼¼°èÀÇ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹ýÀÎ¿ë ÆÇ¸Å
  • º´¿ø
  • Ŭ¸®´Ð
  • ¼Ò¸Å ÆÇ¸Å
  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹

Á¦7Àå Ç÷´ç°è ½ÃÀå Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°èÀÇ Ç÷´ç°è ½ÃÀå, Áö¿ªº°, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼°èÀÇ Ç÷´ç°è ½ÃÀå, ±¹°¡º°, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç Ç÷´ç°è ½ÃÀå

  • ¾Æ½Ã¾ÆÅÂÆò¾ç Ç÷´ç°è ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÁõÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎ ´ëó, ±ÔÁ¦, ±ÔÁ¦±â°ü, ÁÖ¿ä ´Üü, °ú¼¼¾×, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾ÆÅÂÆò¾ç Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾Æ½Ã¾ÆÅÂÆò¾ç Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦9Àå Áß±¹ Ç÷´ç°è ½ÃÀå

  • Áß±¹ Ç÷´ç°è ½ÃÀå °³¿ä
  • Áß±¹ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áß±¹ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦10Àå ÀεµÀÇ Ç÷´ç°è ½ÃÀå

  • Àεµ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦11Àå ÀϺ»ÀÇ Ç÷´ç°è ½ÃÀå

  • ÀϺ»ÀÇ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀϺ»ÀÇ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦12Àå È£ÁÖÀÇ Ç÷´ç°è ½ÃÀå

  • È£ÁÖ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • È£ÁÖ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ Ç÷´ç°è ½ÃÀå

  • Àεµ³×½Ã¾Æ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ³×½Ã¾Æ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦14Àå Çѱ¹ÀÇ Ç÷´ç°è ½ÃÀå

  • Çѱ¹ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Çѱ¹ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦15Àå ¼­À¯·´ÀÇ Ç÷´ç°è ½ÃÀå

  • ¼­À¯·´ÀÇ Ç÷´ç°è ½ÃÀå °³¿ä
  • ¼­À¯·´ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼­À¯·´ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦16Àå ¿µ±¹ÀÇ Ç÷´ç°è ½ÃÀå

  • ¿µ±¹ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿µ±¹ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦17Àå µ¶ÀÏÀÇ Ç÷´ç°è ½ÃÀå

  • µ¶ÀÏ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¶ÀÏ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦18Àå ÇÁ¶û½ºÀÇ Ç÷´ç°è ½ÃÀå

  • ÇÁ¶û½º Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÇÁ¶û½º Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦19Àå µ¿À¯·´ÀÇ Ç÷´ç°è ½ÃÀå

  • µ¿À¯·´ÀÇ Ç÷´ç°è ½ÃÀå °³¿ä
  • µ¿À¯·´ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿À¯·´ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦20Àå ·¯½Ã¾ÆÀÇ Ç÷´ç°è ½ÃÀå

  • ·¯½Ã¾Æ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ·¯½Ã¾Æ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦21Àå ºÏ¹Ì Ç÷´ç°è ½ÃÀå

  • ºÏ¹Ì Ç÷´ç°è ½ÃÀå °³¿ä
  • ºÏ¹Ì Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÏ¹Ì Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦22Àå ¹Ì±¹ Ç÷´ç°è ½ÃÀå

  • ¹Ì±¹ Ç÷´ç°è ½ÃÀå °³¿ä
  • ¹Ì±¹ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹Ì±¹ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦23Àå ³²¹Ì Ç÷´ç°è ½ÃÀå

  • ³²¹Ì Ç÷´ç°è ½ÃÀå °³¿ä
  • ³²¹Ì Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ³²¹Ì Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦24Àå ºê¶óÁúÀÇ Ç÷´ç°è ½ÃÀå

  • ºê¶óÁú Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºê¶óÁú Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦25Àå Áßµ¿ Ç÷´ç°è ½ÃÀå

  • Áßµ¿ Ç÷´ç°è ½ÃÀå °³¿ä
  • Áßµ¿ Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áßµ¿ Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦26Àå ¾ÆÇÁ¸®Ä« Ç÷´ç°è ½ÃÀå

  • ¾ÆÇÁ¸®Ä« Ç÷´ç°è ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä« Ç÷´ç°è ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾ÆÇÁ¸®Ä« Ç÷´ç°è ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦27Àå Ç÷´ç°è ½ÃÀå °æÀï »óȲ°ú ±â¾÷ °³¿ä

  • Ç÷´ç°è ½ÃÀå °æÀï »óȲ
  • Ç÷´ç°è ½ÃÀå ±â¾÷ °³¿ä
    • Abbott Laboratories
    • Medtronic plc.
    • F. Hoffmann-La Roche Ltd.
    • Bayer AG
    • Dexcom Inc.

Á¦28Àå Ç÷´ç°è ½ÃÀåÀÇ ÁÖ¿ä ÀμöÇÕº´

Á¦29Àå Ç÷´ç°è ½ÃÀå ÇâÈÄ Àü¸Á°ú °¡´É¼º ºÐ¼®

Á¦30Àå ºÎ·Ï

KSM 23.05.19

“Glucometer Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glucometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glucometer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The glucometer market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Continuous Glucose Monitoring Devices; Self-Monitoring Blood Glucose System
  • 2) By Technique: Invasive; Non-Invasive
  • 3) By Distribution Channel: Institutional Sales; Hospitals; Clinics; Retail Sales; Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Abbott Laboratories; Medtronic plc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Dexcom Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the glucometer market are Abbott Laboratories, Medtronic plc., F. Hoffmann-La Roche Ltd., Bayer AG, Dexcom Inc., B Braun Melsungen AG, Johnson & Johnson Services Inc., Omron Corporation, Acon Laboratories Inc., Arkray Inc., NOVA, LifeScanInc., i-SENS Inc., Teromo Corporation, Hainice Medical Inc., Glucostratus Ltd.

The global glucometer market is expected to grow from $11.98 billion in 2022 to $13.12 billion in 2023 at a compound annual growth rate (CAGR) of 9.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The glucometer market is expected to reach $18.65 billion in 2027 at a CAGR of 9.2%.

The glucometer market consists of the sale of testing strips, lancing pens, lancets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

A glucometer, also referred to as a glucose meter is a medical instrument for estimating the level of glucose in the blood. This compact portable instrument measures the quantity of glucose in the blood also known as the blood glucose level. This is a common tool used by people with diabetes to help them control their disease.

North America was the largest region in the glucometer market in 2022. The regions covered in the glucometer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of glucometers are continuous glucose monitoring devices and self-monitoring blood glucose systems. Continuous glucose monitoring devices are medical devices that are automatically monitored by continuous glucose monitoring both throughout the day and at night. The various techniques are invasive and non-invasive that are distributed through institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies and online pharmacies.

The increase in the prevalence of diabetes is driving the demand for the glucometer market going forward. Diabetes is a long-lasting metabolic condition. It is characterized by high blood glucose (also known as blood sugar) levels, which over time cause significant harm to the heart, blood vessels, eyes, kidneys, and nerves. People who are suffering from diabetes use a glucometer to monitor their blood glucose levels. Therefore, with an increase in diabetes among people, the demand for glucometers is also increasing. For instance, in December 2021, according to the statistics published by International Diabetes Federation, a Belgium-based, non-profit diabetes association, 537 million adults (20-79 years) recorded living with diabetes, and 6.7 million people died of diabetes in 2021. However, by 2030, it is anticipated that there will be 643 million people worldwide will have diabetes. Therefore, the increase in the prevalence of diabetes drives the glucometer market.

Product innovations are a key trend gaining popularity in the glucometer market. Major companies in the market are introducing various products to sustain their position in the market. For instance, in January 2022, Roche, a Switzerland-based healthcare company introduced a brand-new point-of-care blood glucose monitor for hospital staff, along with a companion device resembling a touchscreen smartphone that would run its apps. The unique features of this portable Cobas pulse device have a touchscreen, camera, and automated glucose test strip reader. It also has a hardened body that can be disinfected and is used for logging other diagnostic data.

In February 2022, Sorrento, a San Diego-based healthcare company acquired Virex Health for an undisclosed amount. With this acquisition, The patented Virex technology employs enzymatic and electrochemical amplification to detect picogram levels biological analytes, such as SARS-CoV-2 and its variations, Flu A/B, as well as indicators for liver cancer, inflammation, and hormone monitoring. Virex Health is a US-based company that develops glucometers.

The countries covered in the glucometer market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The glucometer market research report is one of a series of new reports from The Business Research Company that provides glucometer market statistics, including the glucometer industry's global market size, regional shares, competitors with a glucometer market share, detailed glucometer market segments, market trends and opportunities, and any further data you may need to thrive in the glucometer industry. This glucometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Glucometer Market Characteristics

3. Glucometer Market Trends And Strategies

4. Glucometer Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Glucometer Market
  • 4.2. Ukraine-Russia War Impact On Glucometer Market
  • 4.3. Impact Of High Inflation On Glucometer Market

5. Glucometer Market Size And Growth

  • 5.1. Global Glucometer Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Glucometer Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Glucometer Market Segmentation

  • 6.1. Global Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Continuous Glucose Monitoring Devices
  • Self-Monitoring Blood Glucose System
  • 6.2. Global Glucometer Market, Segmentation By Technique, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Invasive
  • Non-Invasive
  • 6.3. Global Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Institutional Sales
  • Hospitals
  • Clinics
  • Retail Sales
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. Glucometer Market Regional And Country Analysis

  • 7.1. Global Glucometer Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Glucometer Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Glucometer Market

  • 8.1. Asia-Pacific Glucometer Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Glucometer Market

  • 9.1. China Glucometer Market Overview
  • 9.2. China Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Glucometer Market

  • 10.1. India Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Glucometer Market

  • 11.1. Japan Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Glucometer Market

  • 12.1. Australia Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Glucometer Market

  • 13.1. Indonesia Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Glucometer Market

  • 14.1. South Korea Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Glucometer Market

  • 15.1. Western Europe Glucometer Market Overview
  • 15.2. Western Europe Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Glucometer Market

  • 16.1. UK Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Glucometer Market

  • 17.1. Germany Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Glucometer Market

  • 18.1. France Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Glucometer Market

  • 19.1. Eastern Europe Glucometer Market Overview
  • 19.2. Eastern Europe Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Glucometer Market

  • 20.1. Russia Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Glucometer Market

  • 21.1. North America Glucometer Market Overview
  • 21.2. North America Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Glucometer Market

  • 22.1. USA Glucometer Market Overview
  • 22.2. USA Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Glucometer Market

  • 23.1. South America Glucometer Market Overview
  • 23.2. South America Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Glucometer Market

  • 24.1. Brazil Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Glucometer Market

  • 25.1. Middle East Glucometer Market Overview
  • 25.2. Middle East Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Glucometer Market

  • 26.1. Africa Glucometer Market Overview
  • 26.2. Africa Glucometer Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Glucometer Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Glucometer Market Competitive Landscape And Company Profiles

  • 27.1. Glucometer Market Competitive Landscape
  • 27.2. Glucometer Market Company Profiles
    • 27.2.1. Abbott Laboratories
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Medtronic plc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. F. Hoffmann-La Roche Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Bayer AG
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Dexcom Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Glucometer Market

29. Glucometer Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦